Table 1.

Participant characteristics

Variable	Premenopausal (n = 14)	Postmenopausal (n = 23)	P
Age, y	31.5 ± 6.0	57.4 ± 5.3	<0.001
Body mass, kg	62.6 ± 9.1	70.6 ± 14.1	0.06
BMI, kg/m²	23.1 ± 3.9	27.3 ± 5.3	0.01
Total body fat, %	29.2 ± 7.1	39.3 ± 5.4	<0.001
Trunk fat, %	27.0 ± 8.5	38.0 ± 6.6	<0.001
Waist circumference, cm	76.8 ± 9.8	84.9 ± 12.8	0.05
WHR	0.78 ± 0.07	0.81 ± 0.06	0.09
LTPA, MET h/wk ^a	17.8 (6.4 – 25.8)	6.5 (3.0 – 16.0)	0.19
Seated systolic BP, mm Hg	108 ± 7	119 ± 15	0.01
Seated diastolic BP, mm Hg	68 ± 5	73 ± 9	0.18
Resting HR, bpm	68 ± 9	64 ± 6	0.12
Total cholesterol, mg/dl	154± 32	176± 30	0.04
LDL cholesterol, mg/dl	91 ± 25	105± 30	0.15
HDL cholesterol, mg/dl	46± 9	49 ± 14	0.51
Triglycerides, mg/dl ^a	65 (54 – 94)	86 (68 – 125)	0.14
Fasting insulin, μIU/ml ^a	5.0 (3.0 – 8.3)	5.0 (4.0 – 13.0)	0.49
Fasting glucose, mg/dl	82± 10	87± 12	0.27
FSH, μIU/ml	5.5 ± 3.3	82.0 ± 35.7	<0.001
Estradiol, pg/ml ^a	88 (61– 108)	10 (10– 11.)	<0.001
Progesterone, ng/ml ^a	0.6 (0.3 – 0.7)	0.3 (0.2 – 0.4)	0.004

Data are mean ± SD, unless otherwise indicated. BMI, body mass index; WHR, waist to hip ratio; LTPA, leisure time physical activity; MET, metabolic equivalents; BP, blood pressure; HR, heart rate; bpm, beats per minute; LDL, low density lipoprotein; HDL, high density lipoprotein; FSH, follicle stimulating hormone;

Data are presented as median (interquartile range).